1st Quarter Premium Stock Alert (Revealed)

If you recall in February of this year, I released my first premium subscription alert.  At the time, I  posted an update that gave you a hint into the industry, sector, and specifically the product that this company develops.  The update provided you with the following hints about the stock I was adding to my portfolio:

STOCK: ******
HEALTHCARE
BIOTECHNOLOGY & DRUGS
TIP: Ribbon
Link: http://urbanomics.blogspot.com/2011/02/february-2011-biotechnology-premium.html

If you'd like to find out which stock was picked up by subscribers to the premium service, please continue on and get a complete view of the stock and the performance since the alert went out.


STOCK: AVEO PHARMACEUTICALS, INC
PROFILE DESCRIPTION (as provided by YAHOO Finance):
http://finance.yahoo.com/q/pr?s=AVEO+Profile

Sector: Healthcare Industry: Biotechnology

Business Summary

AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The company’s lead product candidate, Tivozanib (AV-951), is a novel, highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2, and 3. It is also leading the clinical development of AV-299, which includes conducting multiple Phase I clinical trials and preparing for the conduct of multiple Phase II clinical trials.

Note: The TIP, "RIBBON" was a reference to the cancer producing drugs they develop.

Potential Purchase:
On February 16, this stock closed the day at $13.88 (this is when date I alerted premium subscribers I'm adding the stock)
Potential Sell:
- On July 11, this stock closed at $20.74 (this is the highest point of the stock for the year so far)
         - Your Return: 49%
- Today (October 13), this stock traded up to $17.09 (the price you could still sell it for today)
        - Your Return: 23%

I have realized over time that the there is one thing that you have to try and get right and that is the PRICE WHERE YOU BUY...and that's in any market (good or bad).  Everyone has an opinion on a stock, but do they tell you what is the price range they are buying the stock and what supports that.  My alerts attempt to do that. Enjoy, Urbanomics